Valuation: Perrigo Company plc

Market Cap 2.02B 1.8B 1.68B 1.53B 2.88B 196B 2.9B 20.19B 7.9B 99.37B 7.58B 7.42B 320B P/E 2026 *
1,455x
P/E 2027 * 12.1x
Enterprise Value 4.92B 4.4B 4.1B 3.73B 7.01B 477B 7.08B 49.25B 19.26B 242B 18.49B 18.09B 779B EV / Sales 2026 *
1.21x
EV / Sales 2027 * 1.17x
Free-Float
99.61%
Yield 2026 *
7.95%
Yield 2027 * 8.16%
1 day-2.54%
1 week+1.28%
Current month-3.79%
1 month-2.61%
3 months+34.98%
6 months+31.12%
Current year+2.01%
1 week 13.91
Extreme 13.91
14.8
1 month 13.15
Extreme 13.15
15.69
Current year 9.22
Extreme 9.225
15.69
1 year 9.22
Extreme 9.225
22.02
3 years 9.22
Extreme 9.225
34.6
5 years 9.22
Extreme 9.225
47.95
10 years 9.22
Extreme 9.225
95.93
Manager TitleAgeSince
Chief Executive Officer 63 2026-06-06
Director of Finance/CFO 51 2022-05-15
Chief Operating Officer - 2025-06-22
Director TitleAgeSince
Director/Board Member 75 2014-10-31
Director/Board Member 61 2016-11-06
Director/Board Member 70 2017-02-05
Date Insider Type Main position Quantity % Market Cap. Importance
9/11/26 Exercice

Director

5,192 0.0037%
9/11/26 Exercice

Director

3,133 0.0023%
9/9/26 Exercice

Executive/Senior Manager

18,186 0.0131%
Change 5-day change 1-year change 3-year change Capi.($)
-2.54%+1.28%-34.41%-52.82% 2.02B
-3.97%-0.68%+35.03%+99.74% 1,060B
-2.20%-2.23%+33.32%+59.51% 623B
-2.05%+2.27%+14.96%+78.28% 480B
-2.28%-2.96%+61.52%+33.54% 352B
-2.03%+1.06%+21.08%+40.60% 345B
-1.92%-0.29%+10.54%+33.58% 274B
-2.36%-1.16%-7.14%+9.54% 249B
-2.90%-1.47%+36.21%+47.78% 223B
-1.35%-1.68%+22.64%+93.21% 182B
Average -2.34%-0.58%+19.37%+44.30% 379B
Weighted average by Cap. -2.65%+0.04%+28.29%+64.70%

Financials

2026 *2027 *
Net sales 4.06B 3.63B 3.38B 3.07B 5.78B 393B 5.84B 40.6B 15.88B 200B 15.24B 14.91B 643B 4.09B 3.65B 3.41B 3.09B 5.82B 396B 5.88B 40.9B 16B 201B 15.35B 15.02B 647B
Net income -224M -200M -187M -170M -319M -21.7B -322M -2.24B -877M -11.03B -841M -823M -35.47B -56.95M -50.86M -47.44M -43.1M -81.1M -5.52B -81.89M -570M -223M -2.8B -214M -209M -9.01B
Net Debt 2.9B 2.59B 2.42B 2.2B 4.14B 281B 4.18B 29.05B 11.36B 143B 10.91B 10.67B 460B 2.78B 2.49B 2.32B 2.11B 3.96B 270B 4B 27.84B 10.89B 137B 10.45B 10.22B 441B
Projected Income Statement - Annual - Perrigo Company plc
Logo Perrigo Company plc
Perrigo Company plc is a pure-play self-care company. The Company provides health and wellness solutions. Its segments include Self Care, Specialty Care, and Infant Formula. Self Care comprises Upper Respiratory, Digestive Health, Pain & Sleep and Healthy Lifestyle product categories globally. Specialty Care comprises our Women's Health and Skin Health product categories globally. Infant Formula comprises the Infant Formula product category, which includes nutritional products designed to meet the dietary needs of infants. It provides a store-branded private label provider of self-care products in many categories, including upper respiratory, healthy lifestyle and women's health, along with brands including Opill and Mederma. Its Europe portfolio consists primarily of brands, including Compeed, ellaOne, Solpadeine, Jungle Formula, and ACO. Its upper respiratory products include Nasonex 24HR Energy, Mucus DM, All Day Allergy, Nighttime Cold & Flu, and Allergy Relief.
Employees
8,100
Date Price Change Volume
26-10-08 US$14.21 -2.37% 422,020
26-10-07 US$14.55 +3.93% 1,906,622
26-10-06 US$14.00 -3.05% 2,035,381
26-10-05 US$14.44 +1.26% 1,878,425
26-10-02 US$14.26 +1.71% 2,168,945
Trader
Investor
Global
Quality
ESG MSCI
BB
Ratings Surperformance© - Perrigo Company plc
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
14.55USD
Average target price
16.50USD
Spread / Average Target
+13.40%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Perrigo Company plc
  1. Stock Market
  2. Stocks
  3. PRGO Stock